Tomato endo beta-mannanase: A candidate of potential tomato allergen protein detected with human monoclonal antibody established from a patient suffered from Japanese cedar pollinosis

Soichiro, Endo; Yamada, Takahiro; Kobayashi, Takayuki; Naganawa, Yasunori; Tabuchi, Toshihiro; Shinmoto, Hiroshi

doi:10.3233/hab-180357

Cited by 1 publication

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…( 2013 ) and Endo et al. ( 2019 ) identified a mannan endo‐1,4‐β‐mannosidase as a putative tomato allergen, but since no match with known allergens was identified, it is likely that the putative tomato allergen is different from the mannan endo‐1,4‐β‐mannosidase under evaluation.…”

Section: Assessmentmentioning

confidence: 99%

“…10 No information is available on oral and respiratory sensitisation or elicitation reactions of this mannan endo-1,4-b-mannosidase. Welter et al (2013) and Endo et al (2019) identified a mannan endo-1,4-b-mannosidase as a putative tomato allergen, but since no match with known allergens was identified, it is likely that the putative tomato allergen is different from the mannan endo-1,4-b-mannosidase under evaluation.…”

Section: Allergenicity 43mentioning

confidence: 99%

See 1 more Smart Citation

Safety evaluation of the food enzyme mannan endo‐1,4‐β‐mannosidase from the genetically modified Aspergillus niger strain NZYM‐NM

Lambré¹,

Baviera²,

Bolognesi³

et al. 2022

EFS2

View full text Add to dashboard Cite

The food enzyme mannan endo‐1,4‐β‐mannosidase (1,4‐β‐ d ‐mannan mannanohydrolase, EC 3.2.1.78) is produced with the genetically modified Aspergillus niger strain NZYM‐NM by Novozymes A/S. The genetic modifications do not give rise to safety concerns. The food enzyme is considered free from viable cells of the production organism and its DNA. The food enzyme is intended to be used in coffee processing. Based on the maximum use levels, dietary exposure to the food enzyme total organic solids (TOS) was estimated to be up to 0.956 mg TOS/kg body weight (bw) per day in European populations. Genotoxicity tests did not indicate a safety concern. The systemic toxicity was assessed by means of a repeated dose 90‐day oral toxicity study in rats. The Panel identified a no observed adverse effect level of 1,151.7 mg TOS/kg bw per day, the highest dose tested, which when compared with the estimated dietary exposure, results in a margin of exposure of more than 1,200. A search for similarity of the amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel considered that, under the intended conditions of use the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood for this to occur is considered to be low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.

show abstract

Section: Assessmentmentioning

confidence: 99%

Section: Allergenicity 43mentioning

confidence: 99%